In full transparency, the following is a press release submitted to SOURCE media through its business wire service.
FRAMINGHAM – Definitive Healthcare Corporation, a Framingham-based healthcare commercial intelligence, yesterday announced it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (“SEC”) relating to a proposed initial public offering of shares of its Class A common stock.
Definitive Healthcare intends to list its Class A common stock under the ticker symbol “DH” on the Nasdaq Global Select Market.
The number of shares to be offered and the price range for the proposed offering have not yet been determined.
The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC are acting as lead joint bookrunning managers and representatives of the underwriters for the proposed offering. Morgan Stanley & Co. LLC and Barclays Capital Inc. are acting as joint book-running managers and are also representatives of the underwriters for the proposed offering. Credit Suisse Securities (USA) LLC and Deutsche Bank Securities Inc. are acting as book-runners for the proposed offering. Canaccord Genuity LLC, Raymond James & Associates, Inc., Stifel, Nicolaus & Company, Incorporated, Drexel Hamilton, LLC and Loop Capital Markets LLC are acting as co-managers.
The proposed offering will be made only by means of a prospectus.
A registration statement on Form S-1 relating to these securities has been filed with the SEC but has not yet become effective.
These securities may not be sold, nor may offers to buy these securities be accepted, prior to the time the registration statement becomes effective.